Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 13,000 shares at $51.00 ($663K) on 2023-11-17, disclosed to the SEC on 2023-11-20.
Scheduled sale ($663k) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |